Hinge Health, Inc. filed a Form 8-K on August 21, 2026, disclosing that it entered into a new office lease agreement on August 18, 2026, for approximately 119,278 rentable square feet at 300 Mission Street, San Francisco, California.

Key Highlights

  • Location and size: The leased premises are approximately 119,278 rentable square feet at 300 Mission Street, San Francisco, California.
  • Aggregate base rent: Estimated base rent payments over the lease term total approximately $86.0 million.
  • Tenant improvement allowance: The landlord will provide up to $17.9 million in tenant improvement allowance.
  • Letter of credit: The company is required to provide an irrevocable standby letter of credit of $2.8 million to secure its obligations.
  • Lease expiration: The lease is anticipated to expire on February 28, 2037, and includes one five-year renewal option.
  • Early termination right: The company holds a one-time early termination right effective January 31, 2035, subject to certain conditions including payment of a termination amount.

Hinge Health's $86 Million Lease Commitment at 300 Mission Street

According to the filing, Hinge Health, Inc. (NYSE:HNGE) entered into a lease agreement with 50 Beale Street LLC, a Delaware limited liability company acting as landlord, on August 18, 2026. The company disclosed that the lease is anticipated to commence five business days after the execution date. The premises consist of approximately 119,278 rentable square feet located at 300 Mission Street in San Francisco, California.

The filing reports that the aggregate estimated base rent payments due over the term of the lease are approximately $86.0 million. Beyond base rent, the company will also be required to pay its share of operating expenses, taxes, insurance expenses, and other additional operating costs. To support the build-out of the space, the landlord agreed to provide a tenant improvement allowance of up to $17.9 million. The company is additionally required to deliver an irrevocable standby letter of credit in the amount of $2.8 million to secure its obligations under the lease.

The lease is anticipated to expire on February 28, 2037, the company disclosed. Hinge Health holds one five-year renewal option and a one-time early termination right effective January 31, 2035, subject to certain conditions, including payment of a termination amount. The filing noted that a complete copy of the lease will be filed as an exhibit to the company's Quarterly Report on Form 10-Q for the period ended September 30, 2026. The filing was signed by James Budge, Chief Financial Officer, on August 21, 2026.

What Was Disclosed

Hinge Health disclosed the entry into a material office lease and the creation of a direct financial obligation totaling approximately $86.0 million in aggregate estimated base rent, along with a $2.8 million standby letter of credit requirement and up to $17.9 million in landlord-funded tenant improvements.